Chargement en cours...
Human equivalent dose of oral 4-aminopyridine differentiates nerve crush injury from transection injury and improves post-injury function in mice
4-Aminopyridine (4-AP), an FDA-approved drug for the symptomatic treatment of multiple sclerosis, is used to improve neuromuscular function in patients with diverse demyelinating disorders. We recently demonstrated that local, transdermal or injectable forms of 4-AP improve myelination, nerve conduc...
Enregistré dans:
| Publié dans: | Neural Regen Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer - Medknow
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7716044/ https://ncbi.nlm.nih.gov/pubmed/32394968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.280319 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|